After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels.

We think that PORTOS could be used to help guide radiation dose-escalation and de-escalation in both the post-operative and definitive settings,” said Shuang (George) Zhao, MD.

For low-to-intermediate-risk prostate cancer patients and older patients, observation with – in case of biochemical recurrence – early salvage radiotherapy can be advised after R0 resection ...